The data examined in this report show that most commercial patients face significant hurdles: large denial rates (often two-thirds of requests), multi-day delays (median ~6 days if not instant-approve), and high first-fill abandonment (fill rates commonly 60%)
What's the difference between semaglutide and tirzepatide
Animal model evidence (moderate) BPC-157 in retinal injury models: Multiple rodent studies showing 40-60% better photoreceptor survival after ischemia-reperfusion injury, retinal detachment, or light-induced damage
Ma J, Zhang J, Sun GX, Lou YN, Li Y
While these injections can benefit some, they may not be suitable for everyone and can have adverse effects
A lower-carb diet with steady glucose control promotes better GH rhythms